New antibody targets Hard-to-Treat cancers in early trial
NCT ID NCT07292168
First seen Jan 05, 2026 · Last updated May 04, 2026 · Updated 21 times
Summary
This study tests a new antibody drug, OM-RCA-01, in people with advanced cancers that have a specific protein called FGFR1. The goal is to see if the drug is safe and can slow tumor growth. About 58 adults with kidney, lung, prostate, breast, or head & neck cancer will receive the drug by IV every two weeks. This is an early-phase trial, so the main focus is safety and finding the right dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD & NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
A.I. Kryzhanovsky Krasnoyarsk Regional Cancer Center
RECRUITINGKrasnoyarsk, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hadassah Medical
RECRUITINGMoscow, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
I.P. Pavlov First Saint Petersburg State Medical University
RECRUITINGSaint Petersburg, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Republican Clinical Oncology Dispensary
RECRUITINGUfa, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Republican Dispensary of Tatarstan
ACTIVE_NOT_RECRUITINGKazan', Russia
Conditions
Explore the condition pages connected to this study.